Patents by Inventor Jingjing ZHU

Jingjing ZHU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240137523
    Abstract: A low-complexity panoramic video coding method considering distortion temporal propagation is provided. By analyzing the inter-frame reference relationships under the random access coding structure and establishing the corresponding distortion propagation chain, the method utilizes distortion impact factors of coding units to adjust encoding parameters, thereby optimizing the encoding process. Furthermore, the method addresses the issue of oversampling arising from the varying geometric deformations in different latitude regions during the projection of spherical images in panoramic videos. This is achieved by adjusting coding parameters based on the ratio of area changes at different latitudes. The proposed approach significantly enhances coding performance.
    Type: Application
    Filed: December 28, 2023
    Publication date: April 25, 2024
    Applicant: UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA
    Inventors: Ce ZHU, Xu YANG, Hongwei GUO, Lei LUO, Linbo QING, Jingjing HOU, Jin DU
  • Publication number: 20240125768
    Abstract: Provided are methods for modulating a SRC-1 condensate to regulate transcription of one or more genes, methods of treating diseases and conditions using SRC-1 inhibitors, and methods for screening of agents that modulate SRC-1 condensate.
    Type: Application
    Filed: February 9, 2022
    Publication date: April 18, 2024
    Applicant: ETERN BIOPHARMA ( SHANGHAI)CO, LTD.
    Inventors: Guangya ZHU, Jingjing XIE, Jidong ZHU, Xin GUO, Hao HE
  • Patent number: 11920017
    Abstract: A method of a polyurethane foam includes the following steps of: (1) simultaneously pumping a mixed solution prepared from hydrogen peroxide, an organic acid, a catalyst and a stabilizer and a vegetable oil into a first microstructured reactor of a micro-channel modular reaction device for reacting to obtain a reaction solution containing epoxidized vegetable oil; (2) simultaneously pumping the reaction solution containing the epoxidized vegetable oil obtained from the step (1) and a compound of formula III into a second microstructured reactor of the micro-channel modular reaction device for reaction to obtain a vegetable oil polyol; and (3) reacting the vegetable oil polyol prepared from the step (2) with a foam stabilizer, a cyclohexylamine, an isocyanate and a foaming agent cyclopentane for foaming so as to prepare a rigid polyurethane foam.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: March 5, 2024
    Assignee: NANJING TECH UNIVERSITY
    Inventors: Kai Guo, Zheng Fang, Chengkou Liu, Ning Zhu, Jingjing Meng, Junjie Tao, Xin Hu, Xin Li, Chuanhong Qiu, Pingkai Ouyang
  • Publication number: 20230165836
    Abstract: The present invention relates to the treatment of cancer. In particular, the invention relates to the therapeutic use of alpha-2 adrenergic receptor agonists for the treatment of cancer. More particularly, apraclonidine, clonidine, guanfacine and guanabenz, which are alpha-2 adrenergic receptor agonists, are all capable of efficiently reducing the growth of solid tumors. The effect is immune-mediated and is abolished in the presence of an alpha-2 antagonist or in mice that are knockout for the alpha-2 adrenergic receptor.
    Type: Application
    Filed: April 21, 2021
    Publication date: June 1, 2023
    Applicant: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Benoît VAN DEN EYNDE, Jingjing ZHU
  • Publication number: 20230149360
    Abstract: The present invention relates to the therapeutic use of alpha-2 adrenergic receptor agonists in the prevention and/or treatment of spleen disorders, in particular splenomegaly. The inventors showed that clonidine, guanabenz and romifidine efficiently reduced the spleen weight of animal models with cancer-induced splenomegaly, immunization-induced splenomegaly or splenomegaly induced by myelofibrosis.
    Type: Application
    Filed: April 21, 2021
    Publication date: May 18, 2023
    Applicant: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Benoît VAN DEN EYNDE, Jingjing ZHU
  • Patent number: 11634656
    Abstract: The invention discloses a photocured medical catheter hydrophilic lubricating coating and a preparation method thereof. The hydrophilic lubricating coating comprises a primer coating and a lubricating coating. The primer coating is attached to the surface of a device, and the lubricating coating is attached to the primer coating. The primer coating comprises 1-10 parts by weight of one or more polyester acrylates, 50-90 parts by weight of one or more solvents, 0.5-5 parts by weight of one or more photoinitiators, 0.5-2 parts by weight of one or more wetting agents and 0.5-5 parts by weight of one or more reactive (or active) diluents. The lubricating coating comprises 1-10 parts by weight of one or more water soluble macromolecules, 1-5 parts by weight of one or more crosslinking (or crosslinked) macromolecules, 0-1 part by weight of one or more photoinitiators, 0.1-1 part by weight of one or more surfactants and 50-98 parts by weight of one or more solvents.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: April 25, 2023
    Assignee: OrbusNeich Medical PTE. LTD.
    Inventors: Jingjing Zhu, Songyun Xu, Mian Li, Chang Peng, Yirong Gong
  • Publication number: 20220405341
    Abstract: Embodiments of this application provide an article display processing method and apparatus and an electronic device. An exemplary method includes: displaying a plurality of articles on a webpage, each of the plurality of articles being associated with an user interface; receiving a user selection of the user interface associated with a selected article from a first user; obtaining an environment template corresponding to the selected article, wherein the environment template is a digitally-generated simulated environment and stored in a database; generating a display image comprising the environment template fused with the selected article as a main view angle according to feature data of the selected article; and sending the display image to a client device of the first user for display.
    Type: Application
    Filed: August 19, 2022
    Publication date: December 22, 2022
    Inventors: Chenzhe XIAO, Jiajia DENG, Xing TANG, Mei HE, Mengwei WANG, Xi GUO, Chengyue JIA, Jingjing ZHU, Lincheng ZENG
  • Publication number: 20220205996
    Abstract: An immunoblotting instrument and a control method are provided. The immunoblotting instrument comprises an immunoblotting instrument body, and an immunoblotting instrument control device, an incubation device and a liquid feeding and sucking device that are provided on the immunoblotting instrument body, and further comprises a temperature control device for controlling the incubation environment temperature of the immunoblotting membrane.
    Type: Application
    Filed: August 19, 2021
    Publication date: June 30, 2022
    Inventors: Shipeng Chen, Liangwei Bao, Gang Xia, Jingjing Zhu, Yinhe Zha
  • Patent number: 11364267
    Abstract: A chimeric antigen receptor (CAR) cell bi-specifically targeting human NKG2DL and CLDN18A2, a preparation method and an application thereof are provided. The CAR includes a targeting human NKG2DL antigen domain, an anti-CLDN18A2 antigen binding domain, a hinge domain, a transmembrane domain, and an intracellular T cell signaling domain. Also provided are nucleic acids, recombinant expression vectors, immune effector cells, and a pharmaceutical composition relating to the CAR. The CAR can be used in methods of detecting the presence of cancer in a mammal and methods of treating or preventing cancer in a mammal.
    Type: Grant
    Filed: December 14, 2021
    Date of Patent: June 21, 2022
    Assignee: NANJING KAEDI BIOTHERAPEUTICS LTD.
    Inventors: Hongjiu Dai, Hui Xu, Jingjing Zhu
  • Patent number: 11359012
    Abstract: A chimeric antigen receptor (CAR) cell specifically targeting human Claudin18.2 (CLDN18A2), a preparation method and an application thereof are provided. The extracellular binding region of the CAR includes a protein specifically recognizing CLDN18A2 that has any one of the amino acid sequences as shown in SEQ ID NOS: 2-5 or any one of the amino acid sequences of the variants having 70%-99% identity with the amino acid sequences shown by the SEQ ID NOS: 2-5. The immune effector cell modified by the CAR can be used to treat tumors.
    Type: Grant
    Filed: August 27, 2021
    Date of Patent: June 14, 2022
    Assignee: NANJING KAEDI BIOTHERAPEUTICS LTD.
    Inventors: Hongjiu Dai, Hui Xu, Jingjing Zhu, Mengyao Wang
  • Publication number: 20210353749
    Abstract: Guanabenz for use with an immunotherapy in the treatment of a cancer or of an infectious disease. In particular, guanabenz is used as an adjuvant for an immunotherapy, such as a cancer immunotherapy or a vaccination. More specifically, guanabenz for use with an adoptive cell therapy, with a therapeutic vaccine, with a checkpoint inhibitor therapy or with a T-cell agonist therapy in the treatment of a cancer. Also, guanabenz for use with a vaccination in the prophylactic and/or therapeutic treatment of an infectious disease.
    Type: Application
    Filed: October 23, 2019
    Publication date: November 18, 2021
    Applicant: UNIVERSITÉ CATHOLIQUE DE LOUVAIN
    Inventors: Benoît VAN DEN EYNDE, Jingjing ZHU
  • Publication number: 20200339906
    Abstract: The invention discloses a photocured medical catheter hydrophilic lubricating coating and a preparation method thereof. The hydrophilic lubricating coating comprises a primer coating and a lubricating coating. The primer coating is attached to the surface of a device, and the lubricating coating is attached to the primer coating. The primer coating comprises 1-10 parts by weight of one or more polyester acrylates, 50-90 parts by weight of one or more solvents, 0.5-5 parts by weight of one or more photoinitiators, 0.5-2 parts by weight of one or more wetting agents and 0.5-5 parts by weight of one or more reactive (or active) diluents. The lubricating coating comprises 1-10 parts by weight of one or more water soluble macromolecules, 1-5 parts by weight of one or more crosslinking (or crosslinked) macromolecules, 0-1 part by weight of one or more photoinitiators, 0.1-1 part by weight of one or more surfactants and 50-98 parts by weight of one or more solvents.
    Type: Application
    Filed: July 2, 2020
    Publication date: October 29, 2020
    Inventors: Jingjing ZHU, Songyun XU, Mian LI, Chang PENG, Yirong GONG